Nanocarriers in Prostate Cancer: Advanced Diagnosis and Treatment Strategies - Softcover

Softcover

ISBN 10: 0443332088 ISBN 13: 9780443332081

Publisher: Academic Press, 2025

Synopsis

Nanocarriers in Prostate Cancer: Advanced Diagnosis and Treatment Strategies provides a comprehensive, up-to-date resource on the latest advancements in nanotechnology for prostate cancer therapy. Sections delve into different types of nanomaterials, including polymeric nanoparticles, DNA origami nanocarriers, and dendrimers. Each chapter explores their unique applications in targeted drug delivery, imaging, and therapeutic strategies, providing detailed insights into how nanotechnology revolutionizes prostate cancer care. This book benefits researchers, clinicians, and students focused on oncology and nanomedicine by offering a deep dive into the potential of nanocarriers in prostate cancer treatment.

This book bridges the gap between cutting-edge research and clinical applications, offering insights into how various nanocarriers enhance drug delivery, improve imaging techniques, and provide targeted, less invasive treatments. It serves as a valuable resource for developing more effective, personalized treatments, leading to improved patient outcomes and reduced toxicity associated with traditional therapies.

• Provides in-depth coverage of nanocarrier types, showcasing their specific roles in prostate cancer treatment
• Integrates the latest research findings with practical clinical applications
• Offers valuable insights and practical examples that help advance understanding and application of nanotechnology in prostate cancer therapy

About this title

About the Authors

Dr. Bhupendra Gopalbhai Prajapati is Professor (Research Cadre) at Parul Institute of Pharmacy, Parul University, Gujarat, India, and serves as Adjunct Professor in the Department of Industrial Pharmacy at Silpakorn University, Thailand. His academic, research, and industry expertise focuses on lipid‑based formulations, nano‑ and microparticulate drug delivery systems, and strategies to enhance drug bioavailability. Dr. Prajapati has received several academic and professional honors recognizing excellence in teaching and research. He has made substantial scholarly contributions through research and review publications, book chapters, and edited volumes in pharmaceutical sciences. Actively engaged in postgraduate and doctoral mentoring, he supports research training in advanced drug delivery and formulation science. Dr. Prajapati also serves in editorial and section‑editor roles for international scientific publications, contributing to the advancement and quality of pharmaceutical research dissemination.

Dr. Devesh U. Kapoor is Professor of Pharmaceutics at Dr. Dayaram Patel Pharmacy College, Bardoli, Gujarat, affiliated with Gujarat Technological University. His academic and research expertise centers on pharmaceutics, nanodrug delivery, and modified‑release drug delivery systems. Dr. Kapoor has made extensive scholarly contributions through research and review publications, book chapters, and edited volumes with international publishers. He is actively involved in postgraduate and doctoral research supervision in advanced drug delivery technologies. His editorial experience includes serving in senior editorial roles for international journals across pharmacology, pharmaceutics, and biomedical sciences, along with regular peer‑review activity for a wide range of scientific journals. Dr. Kapoor has also secured competitive research and academic development funding and is a frequent invited speaker at national scientific meetings, workshops, and academic programs.

Currently working as an Assistant Professor in the Department of Pharmacology and Toxicology at College of Pharmacy King Saud University, Riyadh Saudi Arabia. Before joining King Saud University worked as a Post-Doctoral Scholar in the School of Medicine, University of Kentucky, Lexington, USA.. Currently involved in teaching, research, and research is mainly focused on finding the molecular mechanisms involved in cancer chemoprevention and chemotherapy-induced vital organ toxicity and their prevention using natural and synthetic compounds using in-vivo and in-vitro models. He has published more than 130 research, review and book chapters in highly reputed international journals.

Dr. Anand Krishnan, Principal Investigator in Chemical Pathology, Office of the Dean, Faculty of Health Sciences, University of the Free State, South Africa. He leads the Precision Medicine Integrative Nano Diagnostics (P-MIND) laboratories, which focus on the biological functions of extracellular vesicles (EVs) in synthetic biology. His research encompasses cell surface protein modification, biomarker discovery through EVs derived from liquid biopsies, and the role of circulating biomarkers in disease development and stem cell biology. Dr. Krishnan has authored over 150 articles and edited eight books published by Elsevier, Springer, and Wiley. He received the National Research Foundation (NRF) rating for Next Generation Researchers in South Africa. In the latest list published by Stanford University, Dr. Krishnan was named among the Top 2% of the most influential scientists worldwide. He is an active member of the International Society of Extracellular Vesicles (ISEV), the African Organisation for Research and Training in Cancer (AORTIC), and the American Association of Cancer Research (AACR). Recently, he has been serving as an editor for the eLife journal, focusing on the Africa region.

From the Back Cover

Nanocarriers in Prostate Cancer: Advanced Diagnosis and Treatment Strategies provides a comprehensive, up-to-date resource on the latest advancements in nanotechnology for prostate cancer therapy. This book bridges the gap between cutting-edge research and clinical applications, offering insights into how various nanocarriers enhance drug delivery, improve imaging techniques, and provide targeted, less invasive treatments. This book delves into different types of nanomaterials, including polymeric nanoparticles, DNA origami nanocarriers, and dendrimers. Each chapter explores their unique applications in targeted drug delivery, imaging, and therapeutic strategies, providing detailed insights into how nanotechnology revolutionizes prostate cancer care. This book benefits researchers, clinicians, and students focused on oncology and nanomedicine by offering a deep dive into the potential of nanocarriers in prostate cancer treatment. It serves as a valuable resource for developing more effective, personalized treatments, leading to improved patient outcomes and reduced toxicity associated with traditional therapies. Healthcare providers, including physicians, immunologists, oncologists, physical therapists, pharmacists, and translators, find this book invaluable in their fight against prostate cancer.

Edition details

• Publisher: Academic Press
• Publication date: 2025
• Language: English
• ISBN 10: 0443332088
• ISBN 13: 9780443332081
• Binding: Paperback
• Number of pages: 376
• Editor: Prajapati